Literature DB >> 6600255

Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.

M A Vadas, N A Nicola, D Metcalf.   

Abstract

Semi-purified human colony-stimulating factors (CSF) powerfully enhanced the antibody-dependent cell-mediated cytotoxicity (ADCC) by metrizamide gradient-purified human neutrophils and eosinophils. The stimulation was observed on three different tumor targets, was rapid (less than 1 hr) in onset, and CSF-stimulated cells needed direct contact with targets for killing. A subspecies of human CSF, CSF-alpha, with eosinophil and granulocyte-macrophage (GM) colony-stimulating activity enhanced both eosinophil and neutrophil killing. In contrast, another subspecies of human CSF, CSF-beta, having only GM colony-stimulating activity, only enhanced neutrophil-mediated ADCC. These results support the notion that human CSF have two sites of action: i) the progenitor cell, where they stimulate a relatively slow process of differentiation, and ii) the mature cell, where they have a rapid action of increasing functional capacity. Furthermore, it seems the pattern of CSF receptors on progenitor cells is maintained throughout the lineage of such cells and serves to regulate the function of mature cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

2.  Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.

Authors:  M A Arnaout; E A Wang; S C Clark; C A Sieff
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team.

Authors:  D Hardy; S Spector; B Polsky; C Crumpacker; C van der Horst; G Holland; W Freeman; M H Heinemann; G Sharuk; J Klystra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

4.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity.

Authors:  A Wozniak; W H Betts; G McLennan; R Scicchitano
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes.

Authors:  S Shalekoff; L Page-Shipp; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Infection of mice with Nematospiroides dubius: demonstration of neutrophil-mediated immunity in vivo in the presence of antibodies.

Authors:  I A Penttila; P L Ey; C R Jenkin
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

8.  Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri.

Authors:  A Ferrante; T J Mocatta
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

10.  Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.

Authors:  I E Addison; B Johnson; S Devereux; A H Goldstone; D C Linch
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.